Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to Buy at StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Friday.

A number of other brokerages also recently weighed in on PAHC. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price for the company. Bank of America raised their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research report on Friday, August 30th. Finally, Barclays raised their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research report on Tuesday, November 12th.

Phibro Animal Health Price Performance

Shares of NASDAQ PAHC opened at $23.21 on Friday. Phibro Animal Health has a fifty-two week low of $10.03 and a fifty-two week high of $25.98. The company has a 50 day simple moving average of $23.44 and a two-hundred day simple moving average of $20.39. The company has a market capitalization of $940.01 million, a price-to-earnings ratio of 53.98, a P/E/G ratio of 0.61 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.

Institutional Investors Weigh In On Phibro Animal Health

A number of large investors have recently added to or reduced their stakes in PAHC. Price T Rowe Associates Inc. MD grew its position in Phibro Animal Health by 7.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock worth $200,000 after purchasing an additional 1,063 shares during the period. CWM LLC boosted its stake in shares of Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the last quarter. Summit Securities Group LLC purchased a new position in shares of Phibro Animal Health during the 2nd quarter worth $83,000. Acadian Asset Management LLC boosted its stake in shares of Phibro Animal Health by 6.3% during the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock worth $12,027,000 after acquiring an additional 42,299 shares during the last quarter. Finally, American Century Companies Inc. boosted its stake in shares of Phibro Animal Health by 119.6% during the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock worth $5,822,000 after acquiring an additional 189,068 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.